Pharmaceutical Development
Before prescription drugs and biomedical devices go to market, they undergo years of pharmaceutical development through research and testing. Southwest Research Institute’s world-class, FDA-inspected CGMP facilities in San Antonio, Texas, are staffed by expert chemists, engineers and computer scientists. Our facilities are supported by our Quality Management System to maintain ISO 13485 protocols. We support drug development and medical device development from preclinical to clinical trials.
Drug Development Services
Our drug development services and focus areas include microencapsulation, bioengineered materials, biomedical devices, biologics discovery, computer-aided drug design, small molecule synthesis, total synthesis of natural products, formulation and CGMP clinical supplies, chemical process development, pilot-scale process chemistry, catalyst design, analytical method development and project management.
Identify & Explore – We identify promising therapeutic targets through targeted, hypothesis-driven discovery and development. We explore the potential of promising inventions through active R&D of new blood-brain barrier assay and cell-based assay methodologies.
- Drug Discovery
- Structure-Based Virtual Screening
- Analytical Pharmaceutical Services
- Biochemistry and Bioengineering
Analyze & Formulate – We analyze drug prototypes in operational environment testing to assess their performance and identify potential challenges. We formulate bio-compatible and targeted drug delivery systems, optimizing biologics delivery and ensuring optimal absorption.
Supply & Scale – We supply qualified testing and demonstration of pilot-scale processes and manufacturing routes. Our expertise enables us to help you scale up production efficiently and effectively, ensuring a smooth transition to commercial manufacturing.
- Clinical Trial Supply Services (Bench-Scale to Kilogram-Scale Supply Services)
- Capsule Formulation Development
- CGMP Manufacturing
Production & Manufacturing Solutions
SwRI offers small-molecule, medical device and biologic development services under our current FDA license.
SwRI scientists and engineers are committed to meeting our clients’ needs by driving innovation in novel platform chemical technologies and innovation in pharmaceuticals research and fine chemical industries. Our 60,000-square-foot research facility and analytical instrumentation supports our daily R&D activities. Chemistry, Manufacturing and Controls (CMC) are vital part of the drug development process that involves defining and establishing the manufacturing processes, molecule characteristics and quality control measures for pharmaceutical products.
